IRCT20211205053287N1RecruitingPhase 3
Evaluation the efficiency of coenzyme Q10 (ubiquinone) supplementation on cisplatin-induced nephrotoxicity inpatients under chemotherapy
Shahre-kord University of Medical Sciences0 sites46 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 46
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 80 years (—)
- Sex
- All
Inclusion Criteria
- •1- Age between 80-20 years,
- •2- Do not take antioxidant and anti-inflammatory supplements for at least 1 month before the start of the study
- •3- Willingness to cooperate in the research project and completing the informed consent form Community Verified icon
Exclusion Criteria
- •1- Changing the method of drug treatment and taking antioxidant and anti-inflammatory supplements during the study period
- •2- Changing lifestyle (changing diet, physical activity and level of mental stress) during the study
Investigators
Similar Trials
Recruiting
Phase 2
Evaluation of The Therapeutic Role of Coenzyme Q10 and Coconut Oil in Acute Aluminum Phosphide Poisoning Outcomes:A Randomized Controlled Clinical TrialInjury, Occupational Diseases, PoisoningPACTR202101703883803Rasha Elhussieny Elsharkawy84
Recruiting
Not Applicable
The Effect Coenzyme Q10 on cardiac complacation after chemotherapyHodgkin lymphomaCondition 1: Lymphoblastic Leukemia. Condition 2: Hodgkin Lymphoma.Lymphoid leukaemiaIRCT2016101026390N3Ahwaz Jundishapour University of Medical Sciences10
Active, not recruiting
Phase 3
Coenzyme Q10 for dementiaDementiaJPRN-jRCTs061180062ABE SATOSHI100
Recruiting
Not Applicable
The efficacy of reduced form of coenzyme Q10 in the Treatment of dementiaDemenitaJPRN-UMIN000019587Shimane University100
Not yet recruiting
Phase 1
Evaluation the effect of co-enzyme Q10 in patients with thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20221211056777N1Shahre-kord University of Medical Sciences50